Health Care · Biological Products, (No Diagnostic Substances) · Nasdaq · CIK 1187953 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD) Last $1.12 · Day +3.70% · Mkt cap $7M · 1Y −65.3% · Off 52W high −82.1% · Vol (1Y) 147.6% Price2023-08-21 → 2026-08-19 CELZ close: $4.73 on 2023-08-21 to $1.12 on 2026-08-19. Split-adj closes · 240 of 2,702 · price returnⓘ At a glance | Short interest1.0% of sh out | | Days to cover1.0d | | 13F net flow (QoQ)+0.15% | | Top-10 13F concentration100.0% | | Next report (est.)2026-11-06 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Sales (TTM)$3,000 | | Earnings (TTM)-$6.0M | | ROE−86.5% | | Net margin−99916.8% | | Sales growth 3Y−59.2% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD−42.9% | | 1Y−65.3% | | 3Y−76.3% | | 5Y−99.1% | | 10Y−100.0% | | Since incept. (ann.)−56.0% |
Total return · from 2015-11-06ⓘ Risk | Ann. volatility (1Y)147.6% | | Ann. volatility (3Y)116.6% | | Sharpe (1Y)−0.10 | | Sharpe (3Y)0.13 | | Max drawdown (1Y)−88.3% | | Max drawdown (3Y)−89.9% | | Beta (3Y vs SPY)1.42 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| GEODE CAPITAL MANAGEMENT, LLC | 38,290 | $78,891 | 1.04% | +34.5% | | VANGUARD CAPITAL MANAGEMENT LLC | 20,350 | $41,921 | 0.55% | new | | XTX Topco Ltd | 14,260 | $29,376 | 0.39% | new | | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 10,469 | $21,566 | 0.28% | new | | VANGUARD FIDUCIARY TRUST CO | 5,518 | $11,367 | 0.15% | new | | WELLS FARGO & COMPANY/MN | 5,000 | $10,300 | 0.14% | new | | Tower Research Capital LLC (TRC) | 2,092 | $4,310 | 0.06% | −9.6% | | MORGAN STANLEY | 534 | $1,100 | 0.01% | +1470.6% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-07 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-07 | −$0.41 | — | $0 | — | | 2026-03-31 | 2026-05-08 | −$0.38 | — | $0 | −100.0% | | 2025-12-31 | 2026-03-20 | — | — | $3,000 | +0.0% | | 2025-09-30 | 2025-11-07 | −$0.48 | — | $0 | — |
As-reported XBRL · next 2026-11-06 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
